FDG PET in a Patient on a GLP-1 Agonist/Insulin Secretagogue.

Autor: Oldan JD, Landman PG; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Schroeder JA; From the Molecular Imaging and Therapeutics, Department of Radiology, University of North Carolina, Chapel Hill, NC., Khandani AH; From the Molecular Imaging and Therapeutics, Department of Radiology, University of North Carolina, Chapel Hill, NC., Solnes LB; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD., Lee CB; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC., Rowe SP

Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2024 Sep 01; Vol. 49 (9), pp. e436-e438. Date of Electronic Publication: 2024 Jun 20.